Article Information
History
- March 9, 2023.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Ferenc B Sallo, MD, PhD1,
- Chantal Dysli, MD, PhD2,
- Franz Josef Holzer, MD3,
- Emmanuelle Ranza, MD4,
- Michel Guipponi, MD4,
- Prof Stylianos E Antonarakis4,
- Prof Francis L Munier1,
- Prof Alan C Bird5,
- Prof Daniel F Schorderet6,7,8,
- Beatrice Rossillion9 and
- Veronika Vaclavik, MD1,10,□
- 1Jules Gonin Eye Hospital, University of Lausanne, Switzerland
- 2Department of Ophthalmology, Inselspital, University of Bern, Switzerland
- 3Department of Neurology, University Hospitals of Geneva, Switzerland
- 4Department of Genetic Medicine and Development, University of Geneva, Switzerland
- 5Moorfields Eye Hospital NHS Foundation Trust, London, UK
- 6Institute for Research in Ophthalmology, Sion, Switzerland
- 7Department of Ophthalmology, University of Lausanne, Lausanne, Switzerland
- 8Faculty of Life Sciences, Ecole Polytechnique Federal de Lausanne, Switzerland
- 9Vision Rive Droite, Grand-Saconnex, Geneva
- 10Hôpital Cantonal de Fribourg, HFR, Fribourg, Switzerland
- ↵□Corresponding author veronika.vaclavik{at}fa2.ch
Posted March 09, 2023.
Characterisation of the retinal phenotype using multimodal imaging in novel compound heterozygote variants of CYP2U1
